Monoclonal antibody 3F8 can effect durable remissions in neuroblastoma patients refractory to chemotherapy: a phase II trial

Prog Clin Biol Res. 1991:366:395-400.
No abstract available

Publication types

  • Clinical Trial

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal / toxicity
  • Bone Marrow / pathology
  • Child
  • Drug Evaluation
  • Humans
  • Monocytes / pathology
  • Neoplasm Metastasis
  • Neoplasm Staging
  • Neuroblastoma / pathology
  • Neuroblastoma / therapy*

Substances

  • Antibodies, Monoclonal